Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MILESTONE SCIENTIFIC INC. Director's Dealing 2016

Aug 3, 2016

34735_dirs_2016-08-03_e61ebd10-f9d9-4402-b041-64f49d97f4ed.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MILESTONE SCIENTIFIC INC. (MLSS)
CIK: 0000855683
Period of Report: 2016-08-01

Reporting Person: OSSER LEONARD (Director, CEO, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-08-01 Common Stock, $.001 par value J 50000 Acquired 2937235 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Options to purchase common stock $1.4900 2019-11-01 Common Stock (73333) 73333 Direct
Options to purchase common stock $1.6500 2018-12-31 Common Stock (248448) 248448 Direct
Options to purchase common stock $0.7500 2017-01-09 Common Stock (133334) 133334 Direct
Options to purchase common stock $2.3800 2019-11-20 Common Stock (185185) 185185 Direct
Options to purchase common stock $3.4900 2020-06-20 Common Stock (57307) 57307 Direct
Options to purchase common stock $1.8900 2021-02-04 Common Stock (82988) 82988 Direct

Footnotes

F1: 776,862 shares are issuable to the reporting person at the termination of employment.

F2: These options are exercisable as follows: (i) immediately for 193,210 and (ii) for an additional 55,238 on 12/31/16.

F3: Immediately exercisable.

F4: These options are exercisable as follows: (i) for 61,728 shares on the date of grant (11-20-14) and (ii) for an additional 1/3 of the 123,457 remaining shares on each of the 1st through 3rd anniversaries of the date of grant.

F5: These options are exercisable as follows: (i) for 19,102 shares on the date of grant (6-20-15) and (ii) for an additional 1/3 of the 38,205 remaining shares on each of the 1st through 3rd anniversaries of the date of grant.

F6: These options are exercisable as follows: (i) for 27,663 shares on the date of grant (2-4-16) and (ii) for an additional 1/3 of the 55,325 remaining shares on each of the 1st through 3rd anniversaries of the date of grant.

F7: The reporting person acquired these shares pursuant to a Share Exchange Agreement providing for the issuance of one share of Milestone Scientific Common Stock for each two shares of Milestone Medical Common Stock. The issuance of these shares is exempt from registration under the Securities Act of 1933, as amended, and the share certificate for these shares were printed with an appropriate restrictive legend.